Diego Ardigo | Project Lead
CHIESI Farmaceutici Spa

Diego Ardigo, Project Lead, CHIESI Farmaceutici Spa

Dr. Ardigò is an MD (specialized in Internal Medicine) and obtained a PhD at the University of Parma (Italy) and a post-doctoral fellowship at Stanford University (California, US). He is author of more than 40 indexed papers. He joined Chiesi in 2010, where acted as Clinical Lead in the registration of the first stem cell therapy in EU and led the cross-company team (with uniQure BV) treating the first patient with a commercial gene therapy in EU. He is chairman of the Therapies Scientific Committee of IRDiRC (International Rare Diseases Research Consortium) and member of EBE-EFPIA ATMP Working Group.


Day 2 Orphan 15th Nov @ 14:10

Post-approval challenges for orphan advanced therapies: Where we stand and what lies ahead

Day 2 Orphan 15th Nov @ 15:05

Presenting IRDiRC's 2027 vision and goals

back to speakers